I am here today to request that the subcommittee support $250,000 in fiscal year 2020.
Anna Eshoo
The Public Record
Anna A. Eshoo is an American politician serving as the U.S. Representative for California's 16th congressional district since 2013. A member of the Democratic Party, she has been an advocate for various issues including healthcare, technology, and environmental protection. Eshoo has played a significant role in shaping policies related to telecommunications and has been involved in efforts to improve access to healthcare for her constituents.
The United States of America is the leader in the world. You can't--no one can point to any other country that produces... lifesaving and cures turning death sentences into chronic conditions.
This is an important--I believe that this subcommittee is the first to be taking up, with a legislative hearing, seven bills, on drug pricing.
When a company delays the start of the exclusivity period of a product, it not only delays other generics from coming to market, it also delays lower prices reaching patients sooner.
The bills we are considering today will inject competition in the system sooner, move drugs to the market more quickly, and lower costs.
The sky is really not caving in. Half of the bills being considered have been introduced in previous congresses.
When brand and generic manufacturers employ these tactics, it is really the American people that lose out.
We know that when generics come to market, they can drive prices down exponentially for consumers.
My bill, which I introduced earlier this year bipartisanly with Mr. Carter will stop the practice of parking generic exclusivity by first filers.
These bills are a strong first step in making prescription drugs more affordable and providing real relief to hardworking Americans that are being price gouged at the pharmacy counter.
Legislative hearings are very important, and while this was long, each one of you are really value added to this.
For too long, the American people have been subjected to the abuse of the patent system by pharmaceutical companies.
I would just like to say a few things about--a few remarks. First of all, the sky is really not caving in.
Remember that saying, it takes two to tango, and they have tangoed. And both are wrong.
These are all commonsense solutions that will remove unnecessary barriers to competition.
These cuts mean working single mothers in between jobs, families with a family member who suffers from addiction, and grandparents in long-term care facilities will have less access to care.
I have to say I am extremely concerned by the priorities reflected in the President's budget, because this proposal directly and negatively impacts hardworking families who depend on crucial services.
The Trump administration has taken a hatchet to every part of the healthcare system.
This policy has caused so much pain and trauma for thousands of children and it's clear that children are still wrongly being separated from their parents.
In November, the American people rejected the vision for our country that this budget represents.





